# Basilea Pharmaceutica International Ltd., Allschwil

Canonical: https://abierto.us/vendors/basilea-pharmaceutica-international-ltd-allschwil-ua43hwrnxfs3

- UEI: UA43HWRNXFS3
- CAGE: SSU10
- Parent: Basilea Pharmaceutica AG
- Location: Allschwil, CHE
- Awards in window: 2 (9 transactions), $93,700,481 obligated, July 7, 2025 to July 28, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 2 awards, $93,700,481

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $93,819,710
- 541711 Professional, Scientific, and Technical Services: -$119,229

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 75A50124C00033 (definitive contract): $93,819,710, Barda - Aspr / Daappo / Barda DCMA. The Development of Antimicrobials for the Treatment of Resistant Fungal and Bacterial Infections - OTA. https://www.usaspending.gov/award/CONT_AWD_75A50124C00033_7505_-NONE-_-NONE-/
- HHSO100201600002C (definitive contract): -$119,229, Barda - Aspr / Daappo / Barda DCMA. Advanced Development of Ceftobiprole. https://www.usaspending.gov/award/CONT_AWD_HHSO100201600002C_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/basilea-pharmaceutica-international-ltd-allschwil-ua43hwrnxfs3.